Cargando…
The anti-PD-1 era of cervical cancer: achievement, opportunity, and challenge
Cervical cancer is one of the three major female gynecological malignancies, becoming a major global health challenge. Although about 90% of early-stage patients can be cured by surgery, advanced-stage patients still need new treatment methods to improve their efficacy, especially for those with rec...
Autores principales: | Li, Chen, Cang, Wei, Gu, Yu, Chen, Lihua, Xiang, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407549/ https://www.ncbi.nlm.nih.gov/pubmed/37559727 http://dx.doi.org/10.3389/fimmu.2023.1195476 |
Ejemplares similares
-
T cell immunotherapy for cervical cancer: challenges and opportunities
por: Yu, Lingfeng, et al.
Publicado: (2023) -
Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and Opportunities
por: Hack, Stephen P., et al.
Publicado: (2020) -
Research progress of biomarkers in the prediction of anti-PD-1/PD-L1 immunotherapeutic efficiency in lung cancer
por: Wang, Luyao, et al.
Publicado: (2023) -
Noncanonical PD-1/PD-L1 Axis in Relation to the Efficacy of Anti-PD Therapy
por: Long, Yiru, et al.
Publicado: (2022) -
Engineered T Cell Therapy for Gynecologic Malignancies: Challenges and Opportunities
por: Xu, Yifan, et al.
Publicado: (2021)